SCHEMBL7370610

SCHEMBL7370610

COc1cc(C(=O)CCCc2ccccc2)ccc1OCc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.73
NPC1 O15118 2/20 0.73
RAB9A P51151 2/20 0.73
HPGD P15428 1/20 0.73
PDE4D Q08499 2/20 0.59
PDE4A P27815 1/20 0.59
PDE4B Q07343 1/20 0.59
PDE4C Q08493 1/20 0.59
KMT2A Q03164 2/20 0.58
MTNR1A P48039 2/20 0.58
MTNR1B P49286 2/20 0.58
APP P05067 1/20 0.58
LMNA P02545 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
ABCB1 P08183 1/20 0.57
SMPD1 P17405 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
KDM4E B2RXH2 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14495130 0.89 SMN1; SMN2 (0.71) SMN1; SMN2NPC1RAB9AHPGDKMT2A
SCHEMBL6819817 0.87 KMT2A (0.62) SMN1; SMN2NPC1RAB9AHPGDPDE4D
SCHEMBL6811211 0.84 SMN1; SMN2 (1.00) SMN1; SMN2NPC1RAB9AHPGDKMT2A
SCHEMBL7047105 0.84 SMN1; SMN2 (0.80) SMN1; SMN2NPC1RAB9AHPGDKMT2A
SCHEMBL8843753 0.84 SMN1; SMN2 (0.71) SMN1; SMN2NPC1RAB9AHPGDPDE4D
SCHEMBL1119481 0.83 NPC1 (0.78) SMN1; SMN2NPC1RAB9AHPGDKMT2A
SCHEMBL341249 0.83 SMN1; SMN2 (0.78) SMN1; SMN2NPC1RAB9AHPGDKMT2A
SCHEMBL6246974 0.83 SMN1; SMN2 (0.78) SMN1; SMN2NPC1RAB9AHPGDKMT2A
SCHEMBL31194744 0.83 NPC1 (0.78) SMN1; SMN2NPC1RAB9AHPGDKMT2A
SCHEMBL7373375 0.83 TRPV1 (0.62) SMN1; SMN2NPC1RAB9APDE4DPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed